More than 700 million
people globally suffer from
a respiratory disease
Respiratory diseases such as
cystic fibrosis, asthma and COPD
cause millions of deaths per year
We are developing new medicines
to treat patients with these diseases
leading to healthier and longer lives
More than 700 million
people globally suffer from
a respiratory disease
Respiratory diseases such as
cystic fibrosis, asthma and COPD
cause millions of deaths per year
We are developing new medicines
to treat patients with these diseases
leading to healthier and longer lives
Impressive drug discovery and development team with extensive experience in delivering novel and effective treatments for respiratory diseases in pharma and biotech settings.
International blend of leading corporate (Novartis Venture Fund) and more traditional venture investors (Versant, Forbion, IP Group, Epidarex, Panakes Partners) bringing individuals with a fantastic track record in Pharma and building exceptional Biotech companies.
We work closely with leading scientific experts and world-renowned physicians involved in the development of new treatments for respiratory diseases.
Sussex Innovation Centre,
University of Sussex,
Science Park Square,
Falmer, Brighton, BN1 9SB
info@enterprisetherapeutics.com
+44 (0)1273 234667
